0001611568-16-000001.txt : 20160817 0001611568-16-000001.hdr.sgml : 20160817 20160816202314 ACCESSION NUMBER: 0001611568-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160817 DATE AS OF CHANGE: 20160816 EFFECTIVENESS DATE: 20160817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PellePharm, Inc. CENTRAL INDEX KEY: 0001611568 IRS NUMBER: 460616581 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-269055 FILM NUMBER: 161837330 BUSINESS ADDRESS: STREET 1: 275 MIDDLEFIELD ROAD, STE. 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 815-7404 MAIL ADDRESS: STREET 1: 275 MIDDLEFIELD ROAD, STE. 100 CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0707 D LIVE 0001611568 PellePharm, Inc. 275 MIDDLEFIELD ROAD, STE. 100 MENLO PARK CA CALIFORNIA 94025 (650) 815-7404 DELAWARE None None Corporation true 2012 Jean Tang, M.D., Ph.D. 853 Esplanada Way Stanford CA CALIFORNIA 94305 Director Mark De Souza, Ph.D. 904 Alvarado Road Berkeley CA CALIFORNIA 94705 Executive Officer Director Neil Kumar, PH.D. 7 Sandstone Street Portola Valley CA CALIFORNIA 94028 Director Frank McCormick, Ph.D. 5 Bernice Street San Francisco CA CALIFORNIA 94103 Director Ervin Epstein, M.D. 553A Miner Road Orinda CA CALIFORNIA 94563 Executive Officer Director Biotechnology Decline to Disclose 06b false 2016-06-13 false true false 0 7500000 3249998 4250002 Sale and issuance of shares of Series B-2 Preferred false 4 0 0 0 false PellePharm, Inc. /s/ Mark De Souza Mark De Souza Chief Executive Officer 2016-06-24